About Peter Adamson

Dr. Adamson is chair of the Children’s Oncology Group (COG), a National Cancer Institute-supported international consortium of more than 220 childhood centers that conducts clinical-translational research, including large-scale clinical trials, in children with cancer.

He was appointed by President Obama and serves on the National Cancer Advisory Board (NCAB) and has served as a member of the Blue Ribbon Panel for Vice President Biden’s National Cancer Moonshot Initiative.

Prior to becoming chair of the COG in 2011, Dr. Adamson was director for Clinical and Translational Research at Children’s Hospital as well as chief of the Division of Clinical Pharmacology and Therapeutics. Other past roles include being co-director of the University of Pennsylvania-CHOP Clinical Translational Science Award, program director of the General Clinical Research Center and principal investigator of CHOP’s Pediatric Pharmacology Research Unit.

His laboratory work focuses on the clinical pharmacology of new drugs for childhood cancer.